Predictors of Core Decompression Success in Patients with Femoral Head Avascular Necrosis | ||
The Archives of Bone and Joint Surgery | ||
مقاله 5، دوره 11، شماره 8، آبان 2023، صفحه 517-523 اصل مقاله (546.32 K) | ||
نوع مقاله: RESEARCH PAPER | ||
شناسه دیجیتال (DOI): 10.22038/abjs.2022.61327.3011 | ||
نویسندگان | ||
Mehdi Karimi؛ Alireza Moharrami؛ Mohammad Vahedian Ardakani؛ Seyed Peyman Mirghaderi؛ Ehsan Ghadimi؛ SM Javad Mortazavi* | ||
Joint Reconstruction Research Center, Tehran University of Medical Sciences, Tehran, Iran | ||
چکیده | ||
Background: Avascular necrosis of the femoral head typically occurs in the young population. Core decompression in the precollapse stage provides pain relief and preservation of the femoral head. The results of core decompression vary considerably despite the early diagnosis. Clinicians concur that primary treatment should focus on preserving the natural surface of the joint. This study investigated the predictive risk factors of failure in femoral head decompression. Methods: We retrospectively reviewed 135 patients and 207 hips (77 male (127 hips) and 58 female (80 hips)) who underwent core decompression (mean age: 34.7 years [age range: 21-71]) from April 2010 to December 2017. All patients were followed by a mean of 57 months. All hips were in the precollapse stage (Ficat I, II). Results: A total of 207 hips were treated with core decompression surgery, and the overall success rate was 58%. The higher grade of Kerboul, Ficat, ARCO classifications, multifocal avascular necrosis of the femoral head, smoking, opium, and corticosteroids were significantly associated with a higher failure rate after core decompression in univariate analysis. In multivariate logistic regression analysis, the Kerboul and Ficat classifications, alcohol consumption, and multifocal avascular necrosis of the femoral head were significantly correlated with core decompression failure. The most common predictive factors in core decompression failure were Ficat II, Kerboul stage 3, multifocal avascular necrosis of the femoral head, and alcohol consumption. Conclusion: In conclusion, we had an overall 58 % success rate in core decompression of femoral head avascular necrosis. Based on the results of this study, imaging evaluation and imaging-based classifications are the most valuable predictor factors for the success of core decompression. Consistent with previous reports, corticosteroid was not a significant predictor of core decompression failure. Level of evidence: III | ||
کلیدواژهها | ||
Avascular necrosis؛ Core decompression؛ Femoral head؛ Predictors | ||
مراجع | ||
1. Lieberman JR, Berry DJ, Montv MA, et al. Osteonecrosis of the Hip: Management in the Twenty-first Century. JBJS. 2002;84(5):834-53. 2. Mont MA, Jones LC, Hungerford DS. Nontraumatic osteonecrosis of the femoral head: ten years later. J Bone Joint Surg Am. 2006;88(5):1117-32. doi:10.2106/jbjs.E.01041 3. Mont MA, Ragland PS, Etienne G. Core decompression of the femoral head for osteonecrosis using percutaneous multiple small-diameter drilling. Clin Orthop Relat Res. 2004;(429):131-8. doi:10.1097/01. blo.0000150128.57777.8e 4. Yu X, Zhang D, Chen X, Yang J, Shi L, Pang Q. Effectiveness of various hip preservation treatments for non-traumatic osteonecrosis of the femoral head: A network meta-analysis of randomized controlled trials. J Orthop Sci. 2018;23(2):356-364. doi:10.1016/j.jos.2017.12.004 5. Jamshidi MM, Moharrami A, Sharifpour S, Mafi AR, Mortazavi SJ. The Role of Spinopelvic Parameters in Total Hip Arthroplasty: A Current Concept Review. Journal of Orthopedic and Spine Trauma. 2022;8(2):40-3.doi:10.18502/jost.v8i2.9308 6. Mirghaderi SP, Sharifpour S, Moharrami A, et al. Determining the accuracy of preoperative total hip replacement 2D templating using the mediCAD® software. J Orthop Surg Res. 2022 Apr 10;17(1):222. doi:10.1186/s13018-022-03086-5 7. Mortazavi SMJ, Ghadimi E, Ardakani MV, et al. Risk factors of dislocation after total hip arthroplasty in patients with developmental dysplasia of the hip. Int Orthop. 2022;46(4):749-759. doi: 10.1007/s00264- 021-05294-w. 8. Mirghaderi SP, Baghdadi S, Salimi M, Shafiei SH. Scientometric Analysis of the Top 50 Most-Cited Joint Arthroplasty Papers: Traditional vs Altmetric Measures. Arthroplast Today.2022;15:81-92. doi: 10.1016/j.artd.2022.03.001. 9. Mirghaderi SP, Hoveidaei AH, Sheikhbahaei E, Motififard M, Moradi N, Moradi M. Femoral Stem Dislocation Caused by Trunnionosis Along with Adverse Local Tissue Reaction; A Case Report and a New Technique of Head to Cone Cementing. Arch Bone Jt Surg.2022;10(10):911-915. doi: 10.22038/ ABJS.2022.61214.3005. 10.Mirghaderi SP, Raeini AG, Gholamshahi H, Mortazavi SMJ, Shafiei SH, Sheikhvatan M. Content Validity and Reliability of the Persian Version of the Forgotten Joint Score Questionnaire in Patients Undergoing Total Hip Arthroplasty. Arthroplast Today 2022;15:40-42. doi: 10.1016/j.artd.2022.01.031. 11.Mirghaderi SP, Sheikhbahaei E, Salimi M, et al. COVID-19 infection rate after urgent versus elective total hip replacement among unvaccinated individuals: A multicenter prospective cohort amid the COVID-19 pandemic. Ann Med Surg (Lond) 2022;80:104307. doi: 10.1016/j.amsu.2022.104307. 12.Moharrami A, Mirghaderi SP, Hoseini-Zare N, et al. Restoring femoral medial offset could reduce pelvic obliquity following primary total hip arthroplasty, an observational study. Int Orthop.2022;46(12):2765-2774. doi: 10.1007/ s00264-022-05506-x. 13.Sheikhbahaei E, Mirghaderi SP, Moharrami A, Habibi D, Motififard M, Mortazavi SMJ. Incidence of Symptomatic COVID-19 in Unvaccinated Patients Within One Month After Elective Total Joint Arthroplasty: A Multicenter Study. Arthroplast Today.2022;14:110-115. doi: 10.1016/j.artd.2022.01.024. 14.Ebrahimpour A, Sadighi M, Hoveidaei AH, et al. Surgical Treatment for Bisphosphonate-related Atypical Femoral Fracture: A Systematic Review. Arch Bone Jt Surg. 2021;9(3):283-296. doi:10.22038/ abjs.2020.52698.2608 15.Hong YC, Luo RB, Lin T, Zhong HM, Shi JB. Efficacy of alendronate for preventing collapse of femoral head in adult patients with nontraumatic osteonecrosis. Biomed Res Int. 2014;2014:716538. doi:10.1155/2014/716538 16.Uzun G, Mutluoglu M, Ersen O, Yildiz S. Hyperbaric oxygen therapy in the treatment of osteonecrosis of the femoral head: a review of the current literature. Undersea Hyperb Med. 2016;43(3):189-99. 17.Oliaei S, SeyedAlinaghi S, Mehrtak M, et al. The effects of hyperbaric oxygen therapy (HBOT) on coronavirus disease-2019 (COVID-19): a systematic review. Eur J Med Res.2021;26(1):96. doi: 10.1186/s40001-021- 00570-2. 18.Al-Jabri T, Tan JYQ, Tong GY, et al. The role of electrical stimulation in the management of avascular necrosis of the femoral head in adults: a systematic review. BMC Musculoskelet Disord. 2017;18(1):319-319. doi:10.1186/s12891-017-1663-5 19.Lee J-Y, Kwon J-W, Park J-S, et al. Osteonecrosis of Femoral Head Treated with Extracorporeal Shock Wave Therapy: Analysis of Short-term Clinical Outcomes of Treatment with Radiologic Staging. Hip Pelvis. 2015;27(4):250-257. doi:10.5371/ hp.2015.27.4.250 20.Yan ZQ, Chen YS, Li WJ, et al. Treatment of osteonecrosis of the femoral head by percutaneous decompression and autologous bone marrow mononuclear cell infusion. Chin J Traumatol. 2006;9(1):3-7. 21.Pierce TP, Jauregui JJ, Elmallah RK, Lavernia CJ, Mont MA, Nace J. A current review of core decompression in the treatment of osteonecrosis of the femoral head. Curr Rev Musculoskelet Med. 2015;8(3):228-32. doi:10.1007/s12178-015-9280-0 22.Ficat RP. Idiopathic bone necrosis of the femoral head. Early diagnosis and treatment. J Bone Joint Surg Br. 1985;67(1):3-9. doi:10.1302/0301-620x.67b1. 3155745 23.Kapadia BH, Banerjee S, Cherian JJ, Jauregui JJ, Mont MA. Principles of Core Decompression for Osteonecrosis of the Hip. In: Koo K-H, Mont MA, Jones LC, eds. Osteonecrosis. Springer Berlin Heidelberg; 2014:279-284. 24.Song WS, Yoo JJ, Kim Y-M, Kim HJ. Results of multiple drilling compared with those of conventional methods of core decompression. Clin Orthop Relat Res.2007;454:139-46. doi: 10.1097/01.blo.0000 229342.96103.73. 25.Liu ZH, Guo WS, Li ZR, et al. Porous tantalum rods for treating osteonecrosis of the femoral head. Genet Mol Res. 2014;13(4):8342-52. doi:10.4238/2014. October.20.10 26.Nadeau M, Séguin C, Theodoropoulos JS, Harvey EJ. Short term clinical outcome of a porous tantalum implant for the treatment of advanced osteonecrosis of the femoral head. Mcgill J Med. 2007;10(1):4-10. 27.Zhang Y, Li L, Shi ZJ, Wang J, Li ZH. Porous tantalum rod implant is an effective and safe choice for early-stage femoral head necrosis: a meta-analysis of clinical trials. Eur J Orthop Surg Traumatol. 2013;23(2):211- 7. doi:10.1007/s00590-012-0962-7 28.Steinberg ME, Larcom PG, Strafford B, et al. Core Decompression With Bone Grafting for Osteonecrosis of the Femoral Head. Clin Orthop Relat Res.2001;(386):71-8. doi: 10.1097/00003086- 200105000-00009. 29. Li X, Xu X, Wu W. Comparison of bone marrow mesenchymal stem cells and core decompression in treatment of osteonecrosis of the femoral head: a metaanalysis. Int J Clin Exp Pathol. 2014;7(8):5024-30. 30.Gangji V, Hauzeur JP, Matos C, De Maertelaer V, Toungouz M, Lambermont M. Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. A pilot study. J Bone Joint Surg Am. 2004;86(6):1153-60. doi:10.2106/00004623- 200406000-00006 31.Marker DR, Seyler TM, Ulrich SD, Srivastava S, Mont MA. Do modern techniques improve core decompression outcomes for hip osteonecrosis? Clin Orthop Relat Res. 2008;466(5):1093-103. doi:10.1007/s11999- 008-0184-9 32.Gardeniers J. A new international classification of osteonecrosis of the ARCO-committee on terminology and classification. ARCO news. 1992;4:41-46. 33.Kerboul M, Thomine J, Postel M, d’Aubigné RM. The conservative surgical treatment of idiopathic aseptic necrosis of the femoral head. J Bone Joint Surg Br.1974;56(2):291-6. 34.Mortazavi SMJ, Moharrami A, Shafiei H, Ebrahimzadeh MH, Karimi M. Unapproved Weight Gain Supplement as a Cause of Avascular Necrosis: A Cautionary Report. Arch Bone Jt Surg. 2019;7(6):561-565. 35. Lavernia CJ, Sierra RJ. Core decompression in atraumatic osteonecrosis of the hip. J Arthroplasty. 2000;15(2):171- 8. doi:10.1016/s0883-5403(00)90132-3 36.Hua KC, Yang XG, Feng JT, et al. The efficacy and safety of core decompression for the treatment of femoral head necrosis: a systematic review and meta-analysis. J Orthop Surg Res. 2019;14(1):306. doi:10.1186/ s13018-019-1359-7 37.Hyodo K, Yoshioka T, Sugaya H, et al. Predicting risk factors of total hip arthroplasty conversion after concentrated autologous bone marrow aspirate transplantation for the treatment of idiopathic osteonecrosis of the femoral head: a retrospective review of 213 hips at a mean follow-up of 5 years. The Journal of Hip Surgery. 2017;1(01):007-013. 38.Tomaru Y, Yoshioka T, Sugaya H, et al. Ten-year results of concentrated autologous bone marrow aspirate transplantation for osteonecrosis of the femoral head: a retrospective study. BMC Musculoskelet Disord. 2019;20(1):410. doi:10.1186/s12891-019-2797-4 39.Smith SW, Fehring TK, Griffin WL, Beaver WB. Core decompression of the osteonecrotic femoral head. J Bone Joint Surg Am.1995;77(5):674-80. doi: 10.2106/00004623-199505000-00003. 40.Scully SP, Aaron RK, Urbaniak JR. Survival analysis of hips treated with core decompression or vascularized fibular grafting because of avascular necrosis. J Bone Joint Surg Am. 1998;80(9):1270-5. doi:10.2106/00004623-199809000-00004 41.Amanatullah DF, Strauss EJ, Di Cesare PE. Current management options for osteonecrosis of the femoral head: part 1, diagnosis and nonoperative management. Am J Orthop (Belle Mead NJ). 2011;40(9):E186-92. | ||
آمار تعداد مشاهده مقاله: 497 تعداد دریافت فایل اصل مقاله: 469 |